FluoroPharma
222 Berkeley Street
Suite 1040
Boston
Massachusetts
02116
United States
Tel: 617-482-2333 Ext.16
Website: http://www.fluoropharma.com/
Email: info@fluoropharma.com
33 articles about FluoroPharma
-
FluoroPharma Names Dr. Thomas Tulip, PhD Chief Executive Officer
12/30/2015
-
FluoroPharma CEO Thijs Spoor To Be Interviewed Live Today On Clear Channel Business Talk Radio
4/3/2014
-
FluoroPharma Announces Closing of $7 MillionEquity Financing
9/19/2013
-
FluoroPharma Receives Patent on Metabolic Markers for PET and SPECT Imaging
3/22/2013
-
FluoroPharma Raises Revenue Forecast Citing Tremendous Progress in Pipeline
9/14/2012
-
FluoroPharma Diagnostic Imaging Products Included at Two Major Scientific Forums
9/10/2012
-
FluoroPharma to Present at the Rodman & Renshaw Annual Global Investment Conference
9/4/2012
-
FluoroPharma Retains Cameron Associates as Investor Relations Advisor
8/29/2012
-
FluoroPharma Announces the Promotion of Tamara Rhein to CFO
8/23/2012
-
FluoroPharma Announces Milestone for BFPET
7/27/2012
-
FluoroPharma CEO Provides Shareholders With a "State of the Union" Communication
6/18/2012
-
FluoroPharma is Granted Patent Rights for BFPET in Australia, Expanding Global Patent Position
3/19/2012
-
FluoroPharma Announces Phase II Study for CardioPET
3/1/2012
-
FluoroPharma to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
1/13/2012
-
FluoroPharma Announces Addition to the Board of Directors
1/3/2012
-
FluoroPharma Announces Aggregate of $7 Million Capital Raise in 2011
12/20/2011
-
FluoroPharma CEO Provides Shareholders With a "State of the Union" Communication
12/13/2011
-
FluoroPharma Announces $1.6M Capital Raise
6/24/2011
-
FluoroPharma Announces Completion of Merger and Fund Raising
5/18/2011
-
FluoroPharma Appoints Mr. Thijs Spoor as Chief Executive Officer and Director
9/16/2010